| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4de36eaaa471d491a1c3f2ae25eaef97 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1841
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate |
1998-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eccebaa98e62a6931ea903dec8c5711a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1358e60cfbe3d97567ee3101ab90814d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c398603098cc2ce7fc70c1db258d4cdf |
| publicationDate |
1998-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H10203996-A |
| titleOfInvention |
Compositions and methods for treating gastrointestinal tract in inflammatory conditions |
| abstract |
PROBLEM TO BE SOLVED: To provide an enteric nutritional supplement composition effective for treating or preventing inflammatory diseases of the gastrointestinal tract, for example, Crohn's disease. SOLUTION: The present invention relates to the above-mentioned composition, wherein i) TGF- β2 enriched casein; ii) a lipid source that provides about 35% to about 50% energy; and iii) a carbohydrate source. Preferred embodiments of the composition of the present invention are as follows. That is, casein is contained in an amount of 1. Composition 100 containing 2-2.0 μg of TGF-β2 Contains 10-40 μg of TGF-β2 per g. The lipid source consists of a mixture of medium chain triglycerides and long chain triglycerides up to 20% by weight and contains polyunsaturated essential fatty acids up to 10% of the lipid energy. The energy content of the composition is in the range of 800-1200 kcal / l, with casein providing 10-14.5% of the energy of the composition. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006516396-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015530981-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012211139-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007508343-A |
| priorityDate |
1997-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |